Idoven
About Idoven
Idoven is a pioneering health technology company that leverages artificial intelligence to transform cardiovascular disease detection and precision medicine. Their core offering is the AI-powered platform, Willem™, which significantly enhances the speed, consistency, and accuracy of electrocardiogram (ECG) interpretation and prediction. The platform is designed to integrate seamlessly into clinical workflows, assisting physicians in triaging cardiac events and identifying cardiovascular diseases earlier. Idoven’s AI algorithms can analyze 50,000 heartbeats in 60 seconds and identify 86 electrical heart disturbances, covering 90% of common cardiac problems.
For physicians, Idoven’s technology addresses the challenges of an overburdened healthcare system and the increasing volume of ECG data from wearable devices. The platform reduces the manual and repetitive workload of ECG analysis, which can take cardiologists hours using traditional methods, allowing them to focus more on direct patient care. Idoven’s device-neutral software can analyze data from various sources, including 1-lead wearables, patches, and 12-lead hospital ECGs, providing a comprehensive and standardized view of a patient’s cardiac history. Beyond diagnosis, Idoven also develops predictive ECG-based AI models for prognostic tools, such as identifying patients at risk of developing persistent atrial fibrillation. They also collaborate with pharmaceutical companies to develop disease biomarkers for patient identification, risk stratification, prognosis, and cardiac drug safety monitoring.
Focus Areas
Business Intelligence
| Key Investors | Insight Partners, Northzone, Wayra (Telefónica), European Innovation Council (EIC) Accelerator, Accel Starter program, EIT Health, Iker Casillas, Pau Gasol, Ron Vianu, Brad Fluegel, Vlad Lata, Diego Piacentini, Sebastian Gunningham, Hambro Perks, Adam Chekroud, Luis Sanz |
| Partnerships | AstraZeneca, Google, Fitbit, Abbott, GE HealthCare, FIFPRO, Santander, Real Madrid Foundation, Servicio Madrileño de Salud (SERMAS), Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Fundación para la Investigación Biomédica del Hospital Gregorio Marañón, Fundación para la Investigación e Innovación Biosanitaria de Atención Primaria, Institut Català de la Salut, Karolinska Institute, Region Stockholm, MADoPA - Centre Expert en Technologies et Services pour le Maintien en Autonomie à Domicile des Personnes Âgées, Estonian Health Insurance Fund, Fundación Instituto de Investigación Marqués de Valdecilla (Idival), Fundació TIC Salut Social, Fundación del Ilustre Colegio Oficial de Médicos de Madrid (Fundación ICOMEM) |
| Technology | cloud-based AI software (Willem™), proprietary deep learning system, device-neutral (compatible with 1-pin wearables to 12-pin hospital ECGs) |
What Physicians Need to Know
Idoven's platform, Willem, acts as a 'Digital Cardiologist in the Cloud,' augmenting your ability to identify, triage, and diagnose patients at scale. It provides rapid, accurate ECG analysis, reducing interpretation time from hours to minutes, and can help manage the increasing demand for cardiovascular care. The system is designed to integrate into existing workflows, supporting decision-making and disease management. It's particularly valuable for early detection, risk stratification, and monitoring drug safety, enabling more precise and timely interventions. Remember that Willem's interpretation results are advisory and should be used in conjunction with your clinical knowledge, patient background, and other diagnostic information.
Idoven's platform is highly interoperable, offering API integration with any existing ECG hardware, hospital systems, and Electronic Health Records (EHRs). It supports various ECG signal formats including JSON, DICOM, EDF, and CSV, ensuring seamless data exchange. This device-neutral approach allows for flexibility in integrating with diverse clinical environments and monitoring devices, from wearables to hospital-grade ECGs.
What the Web Says
Idoven is a health technology company that utilizes AI to enhance the detection and diagnosis of heart conditions through advanced ECG analysis. Their platform, Willemu2122, is designed to provide rapid and precise ECG interpretations, identifying numerous cardiac patterns with high accuracy. The company emphasizes its commitment to data security and seamless integration with various ECG devices and existing healthcare infrastructures.
Overall: PositiveStrengths
- High-accuracy AI-driven ECG interpretation, detecting 22 cardiac patterns and 4 intervals with remarkable accuracy.
- Seamless integration with various ECG devices and existing healthcare infrastructures.
- Robust data security and compliance standards, including ISO certifications and GDPR compliance.
- Scalable solutions for diverse healthcare environments.
- Significant reduction in false positives (up to 98%) and increased arrhythmia detection accuracy (up to 95.6%).
- Reduces analysis time from minutes to seconds, speeding up data interpretation.
Limitations
- No publicly available pricing information.
- Primarily designed for enterprise-level implementation.
- Requires initial setup and integration efforts.
- Limited public reviews available on major platforms like G2, Glassdoor, Capterra, and Reddit.
- Potential for a steep learning curve for new users due to the advanced nature of the technology (implied by the need for integration efforts).
Based on reviews from: AIChief, SoftwareSuggest, GE HealthCare, Insight Partners, Google for Startups, Skywork, CNN
Last updated: 2026-07-03
Videos
News, demos, and interviews about Idoven.
Videos load interactively. If none appear, search YouTube for Idoven →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]